Seeking Alpha

b.holden

b.holden
Send Message
View as an RSS Feed
View b.holden's Comments BY TICKER:
Latest  |  Highest rated
  • Cramer's Lightning Round - I'm Steadfast On The Airlines (10/18/13) [View article]
    2 weeks ago I suggested (at Yahoo"s Apri opinion) to
    buy Sgen now - last week it broke 10, than 11. It has doubled having started develop drugs for large pharma.
    When they start selling Apri's NEXT range of unique sex drugs for a world wide.
    At this time some solid pharmas have signed with
    Apri for this global canpaign (like ABT).
    Apri expect startin next year
    Shares currently at $2,05
    A unique sex product (for bashfull women )already approved
    for women in UK, Gernany and Netherlands.
    Some 40 % of women suffer from this negative mood
    situation.
    Oct 20, 2013. 09:21 AM | Likes Like |Link to Comment
  • Does JAZZ Have Any Pizzazz Left? [View article]
    Kudo's for Jazz's management,they went from
    a shaky US hopping to abroad doing all the
    right things - so I would not be surprised if
    more great actions are in store.
    But I think that APRI has a beter set up:
    they are starting off with some impressive
    products, and made/are making deals
    with the best pharmas on the GLOBE
    to introduce these. I think that not many people
    understand the power of this kind of introduction
    Some seven distributors will constant be in touch to form a marketing bastion of the best farmas in the world
    to sell APRI's products.
    And at $ 2.17 a share Apri has a
    long way to grow!
    Oct 9, 2013. 05:29 AM | Likes Like |Link to Comment
  • Why AbbVie Is A Solid Buy [View article]
    When is Abbvie going to start launching APRI' s
    novel women's sex-feels-good drug, which will
    also introduced in Europe and Asia.
    Some 10 pharma ( of which ABT will introduce
    this interesting drug in Canada). Studies shown
    40* of the world's women are affected.
    APRI will also launch a new men's sex drug with an
    exclusive new ingredient.
    The launch was planned for 2013, but the worldwide
    introduction takes more time.
    My other favorite CGEN should do very well.
    Oct 6, 2013. 03:13 PM | Likes Like |Link to Comment
  • Targeting An Untapped Female Sexual Dysfunction Drug Market [View article]
    Thee are quite a number of interested (and sizeable)
    pharmas - Abbott is one- which have made a deal with
    APRI to market FEMPROX. The Swiss have made a suggestion
    to adapt the text on a minor matter, which APRI wll answer
    within 30 days. It does not look like it would getting a
    major issue.
    There have been additions to the growing number of
    distribution resorces - which total up too some 10
    manufacturing/distribu... facilities,
    The reports mention some 40% of women are
    potential users.With no foreseeable competition ,
    sales of FEMPROX could impressive.It would be
    the first bestseller for APRI, with a follow up
    drug, equally interesting.

    BH
    Sep 3, 2013. 09:05 AM | Likes Like |Link to Comment
  • Following The Crashing Biotechs - 4 Stocks Ready For Spring [View article]
    Worked 18 years for Wyeth,in far and out-of-route places.
    Tallied 6000 hospitals and having interesting times,sometimes lending a helping hand on hectic days..
    Aug 8, 2013. 03:59 AM | Likes Like |Link to Comment
  • Following The Crashing Biotechs - 4 Stocks Ready For Spring [View article]
    Has anybody heard when the Global introduction by several
    solid pharmas (like Abbott) will take of?
    Abt would handle Canada, and the introduction of APRI's new and
    promising medications (2) should start any time now.
    BH
    Aug 8, 2013. 03:27 AM | Likes Like |Link to Comment
  • Questcor: The Bear Theses Continue To Unravel [View article]
    The one that sizzles now: QCOR
    Check out what kind of surprise this company has in mind
    Love it!
    Aug 1, 2013. 09:08 AM | Likes Like |Link to Comment
  • An FDA advisory panel votes in favor of Theravance's (THRX) Breo Ellipta, saying the inhaler was safe and effective at treating COPD. The agency's pulmonary-allergy advisory committee is still reviewing the drug and has to vote on whether the product should be marketed, but today's positive vote makes it likely the panel will vote affirmatively to support approval. Shares remain halted. [View news story]
    Soon next in line
    THLD
    (I hope!)
    Lars
    Apr 17, 2013. 08:21 PM | Likes Like |Link to Comment
  • Why BlackBerry's Gain Was A Mirage [View article]
    I agree fullH that BB's innovation and duress (yes check it out)
    will bring this wonder way up front - for quite some time.
    Mar 30, 2013. 12:30 PM | Likes Like |Link to Comment
  • The Truth About Vitaros [View article]
    APRI will become a well known pharma house
    once the 8 or 10 companies (amongst some of the super tem) will be covering the GLOBE with the novel and useful medications which should get a start in Canada NEXT month!
    At that time we would (I would guess) see the end of the long
    APRI's $ 2.- to 2.50 share range.
    LarryB
    Mar 23, 2013. 06:39 PM | Likes Like |Link to Comment
  • Threshold Pharmaceuticals - A Derivative Trade On Ziopharm's Upcoming Data [View article]
    I bet BIO has a lot of THLD stock.
    They lost 25 cts today - they are many months running behind
    now, lot more risk.
    One of the biggest pharmas is going into Canada this summer
    to introduce a sensational product from a company you probably
    have never heard of. Some 5 additional phamas have sliced
    the rest of the globe, a world wide classic.This
    company sells between $2 and $3, so dig some more!
    LarryB
    Mar 22, 2013. 03:21 PM | Likes Like |Link to Comment
  • 6 Biotech Stocks With Huge Potential In May [View article]
    Adam or Eve: there is no way they can influence the buying or selling
    of APRI
    They do not have a salesforce, so they made a deal
    with ABT to cover Canada..
    Now ABT is BIG pharma, globally they are in the
    Top Ten. Just the fact that ABT liked what they were
    offered is perhaps the biggest reason why
    the product will be a winning one, it is a winning
    pharma, and they won't sign a deal, unless
    they believe this will be a fine business for them
    In Europe they made a similar deal with
    an equal nifty and large organization, that
    will market this attractive product in Germany,
    a very sizeable market.
    There is much more to tell about APRI - for example
    it is selling for around $ 2.90 but check out all the
    other attractions, particularly APRI's
    reservoir of interesting medication!
    Do DD - you may come to the same conclusions|
    Apr 13, 2012. 06:51 AM | Likes Like |Link to Comment
  • Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date [View article]
    One more month,and PLX-PFE should
    receive FDA's approval to market an unique all
    natural Taliglucerase medication against a rare disease.
    That couild mean another dollar or so to the price
    to PLX , now approx $ 5,50
    Happy Easter!
    Lars
    Apr 3, 2012. 01:12 PM | 1 Like Like |Link to Comment
  • Cramer's Lightning Round - People Are Bummed Out By Annaly (3/29/12) [View article]

    Abbot is going to market one of Apri's promising new
    drugs .
    In Canada,
    Apri has also scooped up some other big global pharmas for the markets in Europe and in the Arabian
    Kingdoms. And soon in the Far East.
    Apri has quietly developed some unique new medications!
    Got FDA approval but no promotion department,
    So he looked for the best pharmas,and made marketing deals.

    At last investors started to take note today,

    Only the beginning.....these are no ordinary
    medications!

    BH
    Mar 30, 2012. 04:07 PM | Likes Like |Link to Comment
  • 2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012 [View article]
    Can someone give a true picture of the disadvantages
    of the continuous short poisition of APRI?
    The strong benefefits of Apri seem to loose out to
    the shorts as the shares are sliding (from a high of 6
    to lows around 2.60 )
    What should manegement do and is not there
    any steps the control bodies of the
    exchange(s) or other authorities can do to
    stop this continuous slide of the stocK/
    Something is not kosher here, and it should
    be stopped. Fine the guys who are
    causing this charade!

    bh
    Mar 29, 2012. 07:47 AM | Likes Like |Link to Comment
COMMENTS STATS
39 Comments
1 Like